FMA
ANGO icon

Fiduciary Management Associates’s AngioDynamics ANGO Stock Holding History

Fiduciary Management Associates’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,177,533
Closed -$15.5M – 106
2015
Q3 		$15.5M Buy
1,177,533
+91,515
+8% +$1.38M 1.01% 65
2015
Q2 		$17.8M Buy
1,086,018
+169,421
+18% +$2.81M 1.05% 64
2015
Q1 		$16.3M Buy
+916,597
New +$17M 0.98% 71

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Fiduciary Management Associates's ANGO Position: Q4 2015 in Review

Fiduciary Management Associates sold out of AngioDynamics (ANGO) in Q4 2015, closing a stake of 1,177,533 shares — an estimated $15.5M sold.

Fiduciary Management Associates first reported a position in ANGO in Q1 2015 and held it in 3 quarters. The position peaked at $17.8M in Q2 2015. 121 funds tracked by Wall St. Rank hold ANGO as of Q4 2015.

  • Fiduciary Management Associates reported no remaining AngioDynamics position as of Q4 2015 after selling out during the quarter.
  • Fiduciary Management Associates sold 1,177,533 AngioDynamics shares in Q4 2015, an estimated $15.5M.
  • Fiduciary Management Associates first reported a position in AngioDynamics in Q1 2015 and held it in 3 quarters.
  • Fiduciary Management Associates's AngioDynamics position peaked at $17.8M in Q2 2015.
  • 121 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2015.

Based on Fiduciary Management Associates's 13F filing for Q4 2015, filed 10 Feb 2016.